Login to Your Account



Offer 'Just Too Low'

Genzyme Wants AnorMed For $380M; AnorMed Uninterested

By Jennifer Boggs


Thursday, August 31, 2006
After AnorMed Inc.'s board rejected an unsolicited $380 million takeover bid, Genzyme Corp. said it plans to go to AnorMed shareholders with a proposal to acquire the company. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription